Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QNACTH: QL1706 + Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer
NCT07205497Phase 2Active, not recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Mar 2025
- Primary completion
- Mar 2027
- Modality
- Bispecific Antibodies, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of QL1706 in Cervical Cancer (CC), sponsored by Sun Yat-sen Memorial Hospital. Started Mar 2025; status: active, not recruiting.
02
Drugs
QL1706
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT07205497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07205497.